TCR V(β) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas

International Immunology

Volumn 12, Issue 3, 2000, Pages 263-270

  Gomez, Gregorio ^a,b   Clarkin, Kimberly Z ^a   Kraig, Ellen ^a   Infante, Anthony J ^a   Richie, Ellen R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AKR J; Bcl 2; Carcinogenesis; N methyl N nitrosourea; Thymocyte

Indexed keywords

METHYLNITROSOUREA; PROTEIN BCL 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COMPLEMENTARITY DETERMINING REGION; FEMALE; LYMPHOCYTE CLONE; MALE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; THYMUS LYMPHOMA;

EID: 0034100357     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.3.263     Document Type: Article

References (56)

1. Seldin, D. C. 1995. New models of lymphoma in transgenic mice. Curr. Biol. 7:665.
2. Malubres, M., Perez de Castro, I., Santos, J., Melendez, R., Mangues, R., Serrano, M., Pellicer, A and Fernandez-Piqueras, J. 1997. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Oncogene 14:1361.
3. Mucenski, M. L., Bedigian, H. G., Shull, M. M., Copeland, N. G. and Jenkins, N. A. 1988. Comparative molecular genetic analysis of lymphomas from six inbred mouse strains. J. Virol. 62:839.
4. Seldin, D. C. 1995. New models of lymphoma in transgenic mice. Curr. Opin. Immunol. 7:665.
5. Jonkers, J. and Berns, A. 1996. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287:29.
6. Angel, J. M., Morizot, D. C. and Richie, E. R. 1993. Localization of a novel chromosome 7 locus that suppresses development of N-methyl-N-nitrosourea-induced murine thymic lymphoma. Mol. Carcinogenesis 7:151.
7. Romach, E., Moore, J. L., Rummel, S. and Richie, E. R. 1994. Influence of sex and carcinogen treatment protocol on tumor latency and frequency of K-ras mutations in N-methyl-N-nitrosourea-induced lymphomas Carcinogenesis 15:2275.
8. Sen-Majumdar, A., Guidos, C., Kina, T., Lieberman, M. and Weissman, I. L. 1994. Characterization of preneoplastic thymocytes and of their neoplastic progression in irradiated C57BI/Ka mice. J. Immunol. 153:1581.
9. Sen-Majumdar, A., Weissman, I. L., Hansteen, G., Marian, J., Waller, E. K. and Lieberman, M. 1994. Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor Vβ gene products. J. Virol. 68:1165.
10. Holland, G. D., Ito, K., Kaehler, D. A., Tonegawa, S. and Risser, R. 1991. Thymic targets for Abelson murine leukemia virus are early γ/δ T lymphocytes. Proc. Natl Acad. Sci. USA 88:3700.
11. Weissman, I. L. and McGrath, M. S. 1982. Retrovirus lymphomagenesis: relationship of normal immune receptors to malignant cell proliferation. Curr. Top. Microbiol. Immunol. 98:103.
12. McGrath, I. L. and Weissman, M. S. 1979. AKR leukemogenesis: identification and bilogical significance of thymic lymphoma receptors for AKR retroviruses. Cell 17:65.
13. O'Neill, H. C., McGrath, M. S., Allison, J. P. and Weissman, I. L. 1987. A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus. Cell 49:143.
14. Brabb, T., Rubicz, R., Mannikko, V. and Goverman, J. 1997. Separately expressed T cell receptor α and β chain transgenes exert opposite effects on T cell differentiation and neoplastic tranformation. Eur. J. Immunol. 27:3039.
15. Fink, P. J. and Bevan, M. J. 1995. Positive selection of thymocytes. Adv. Immunol. 59:99.
16. Robey, E. and Fowlkes, B. J. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675.
17. Strzadala, L., Miazek, A., Matuszyk, J. and Kisielow, P. 1997. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice. Int. Immunol. 9:127.
18. Richie, E. R., Angel, J. M. and Rinchik, E. M. 1996. Tlag1, a novel murine tumor susceptibility gene that regulates MNU-induced thymic lymphoma development. In Slaga, T. J., ed., Progress in Clinical and Biological Research, p. 23. Wiley-Liss, New York, NY.
19. Frei, J. V. 1980. Methylnitrosourea induction of thymomas in AKR mice requires one or two 'hits' only. Carcinogenesis 1:721.
20. Gross, L. 1970. Oncogenic Viruses, 2nd edn. Pergamon Press, New York.
21. Warren, W., Lawley, P. D., Gardner, G., Harris, G., Ball, J. K. and Cooper, C. S. 1987. Induction of thymomas by N-methyl-N-nitrosourea in AKR mice: interaction between the chemical carcinogen and endogenous murine leukemia viruses. Carcinogenesis 8:163.
22. Richie, E. 1988. N-methyl-N-nitrosourea and spontaneous AKR/J thymic lymphomas express distinct differentiation antigen phenotypes. Leuk. Res. 12:233.
23. Fan, H. 1994. Retroviruses and their role in cancer. In Levy, J. A., ed., The Retroviridae, p. 313. Plenum Press, New York.
24. Richie, E. R., Angel, J. M. and Cloyd, M. W. 1991. Influence of murine leukemia proviral integrations on development of N-methyl-N-nitrosourea-induced thymic lymphomas in AKR mice. J. Virol. 65:5751.
25. + tumours in CD2-myc transgenic mice. Br. J. Cancer 73:13.
26. a-encoded antigens. Nature 332:40.
27. Malissen, M., Minard, K., Mjolsness, S., Kronenberg, M., Goverman, J., Hunkapillar, T., Prystowsky, M. B., Yoshikai, Y., Fitch, F., Mak, T. W. and Hood, L. 1984. Mouse T cell antigen receptor: structure and organization of constant and joining gene segments encoding the β polypeptide. Cell 37:1101.
28. Kraig, E., Pierce, J. L., Clarkin, K. Z., Standifer, N. E., Currier, P., Wall, K. A. and Infante, A. J. 1996. Restricted T cell repertoire for acetylcholine receptor in murine myasthenia gravis. J. Neuroimmunol. 71:87.
29. Zhen, L. and Swank, R. T. 1993. A simple and high yield method for recovering DNA from agarose gels. BioTechniques 14:894.
30. Zar, J. H. 1996. Biostatistical Analysis. Prentice-Hall, Upper Saddle River, NJ.
31. Kappler, J. W., Staerz, U., White, J. and Marrack, P. C. 1988. Self-tolerance eliminates T cells specific for MIs-modified products of the major histocompatibility complex. Nature 332:35.
32. + T cells in mice with MIs-1a haplotype. J. Immunol. 144:3473.
33. + cells for lymphoma development. Cancer Res. 51:737.
34. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513.
35. Linette, G. P., Hess, J. L., Sentman, C. L. and Korsmeyer, S. 1995. Peripheral T-cell lymphoma in lckPr-bcl-2 transgenic mice. Blood 86:1255.
36. Strasser, A., Harris, A. W., Bath, M. L. and Cory, S. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331.
37. 2+ fluxes. Oncogene 11:2165.
38. Sanchez-Garcia, I. and Martin-Zanca, D. 1997. Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras. J. Mol. Biol. 267:225.
39. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B. and Chien, Y. 1998. Ligand recognition by alpha-beta T cell receptors. Annu. Rev. Immunol. 16:523.
40. Dellabona, P., Peccoud, J., Kappler, J., Marrack, P., Benoist, C. and Mathis, D. 1990. Superantigens interact with MHC class II molecules outside the antigen groove. Cell 62:1115.
41. a. Cell 61:1365.
42. a superantigen-specific T cell responses. J. Exp. Med. 175:1405.
43. Danska, J. S., Pflumio, F., Williams, C. J., Hunter, O., Dick, J. E. and Guidos, C. J. 1994. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266:450.
44. Liao, M.-J., Zhang, X.-X., Hill, R., Gao, J., Qumsiyeh, M. B., Nichols, W. and van Dyke, T. 1998. No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18:3495.
45. Nacht, M. and Jacks, T. 1998. VDJ recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Different. 9:131.
46. De Heer, C., De Geus, B., Schuurman, H.-J., van Loveren, H. and Rozing, J. 1992. Vβ gene family usage in spontaneous lymphomas of AKR mice: evidence for defective clonal deletion. Dev. Immunol. 2:95.
47. Webster, G., Onions, D. E., Neil, J. C. and Cameron, E. R. 1997. Skewed T-cell receptor Vβ8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development? Br. J. Cancer 76:739.
48. Newcomb, E. W. 1997. Clonal evolution of N-methylnitrosourea-induced C57BL/6J thymic lymphomas by analysis of multiple genetic alterations. Leuk. Res. 21:189.
49. Gratiot-Deans, J., Merino, R., Nunez, G. and Turka, L. A. 1994. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl Acad. Sci. USA 91:10685.
50. Veis, D. J., Sentman, C. L., Bach, E. A. and Korsmeyer, S. J. 1993. Expression of the bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546.
51. Strasser, A., Harris, A. W. and Cory, S. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889.
52. Siegel, R. M., Katsumata, M., Miyashita, T., Louie, D. C., Greene, M. I. and Reed, J. C. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl Acad. Sci. USA 89:7003.
53. Strasser, A., Harris, A. W., von Boehmer, H. and Cory, S. 1994. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl Acad. Sci. USA 91 1376.
54. + thymocytes is altered by overexpression of the Bcl-2 proto-oncogene in the thymus. J. Exp. Med. 179:145.
55. Sentman, C. L., Shutter, J. R., Hockenberry, D., Kanagawa, O. and Korsmeyer, S. J. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879.
56. Williams, O., Norton, T., Halligey, M., Kioussis, D. and Brady, H. J. M. 1998. The action of Bax and Bcl-2 on T cell selection. J. Exp. Med. 188:1125.